Lonza, Boehringer Ingelheim, Samsung Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.
Research By Markets adds "Global Bio CMO Market: Size, Trend…casts (2016-2021) " to its online repository. The report provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry.
The report also provides the analysis of the global biologics market by value, by top selling products,.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry.
Pharmaceutical industry comprise of discovering, developing, producing and marketing of drugs for medical use. World's largest pharmaceutical firms are located in the North America, Europe and Japan.
On the basis of technological platform, pharmaceutical drugs can be divided into small molecule or conventional drugs and large molecule or biologic drugs.
Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy,.
Biologics are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.
CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry.
On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.
The global bio CMO market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The global bio CMO market is supported by various growth drivers, such as increase in pharmaceutical industry, growth in use of biosimilars, potential biologics blockbusters,.
Yet, the market faces certain challenges, such as risk associated with CMOs, presence of in-house manufacturing facilities of big pharma companies, productivity issues with mammalian cell system,.
Samsung Electronics (Samsung Biologics)
- Global Pharmaceutical Market Growth
- Potential Biologics Blockbusters
- Increase in Biosimilar Market
- Preference of Biologics Over Small Molecules
- Presence for In-House Biopharma Manufacturing
- Risk Associated with CMOs
- Productivity Issue with Mammalian Cell System
- Big Pharmaceuticals Outsourcing Rate
- Capacity Utilization Rate of CMOs
- Growth in Mammalian Cell Structure
- Stringent Regulatory Requirements for Biologics and Biosimilars
Category: Market Research Publishers and RetailersCompany about: Research by Markets is an online Market Research Report Repository. Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more. We have dedicated Account Managers for Corporate Clients to ensure seamless customer support. Corporates can als ...
For more information:Make an Inquiry about this report HERE!